{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:04:58Z","timestamp":1791839098388,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014227","name":"Jaypee Institute of Information Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR 48077\/BID\/7\/1025\/2023"],"award-info":[{"award-number":["BT\/PR 48077\/BID\/7\/1025\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.braindev.2025.104476","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T23:23:27Z","timestamp":1761348207000},"page":"104476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adrenoleukodystrophy: Current understanding of disease mechanisms, diagnosis, and therapeutic advances\u2013a recent review"],"prefix":"10.1016","volume":"47","author":[{"given":"Chakresh Kumar","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2025.104476_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2025.104476_bb0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jcb.26295","article-title":"Inflammatory profile in X-linked adrenoleukodystrophy patients: understanding disease progression","volume":"119","author":"Marchetti","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.braindev.2025.104476_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/endrev\/bnaa013","article-title":"The changing face of adrenoleukodystrophy","volume":"41","author":"Zhu","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.braindev.2025.104476_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1309053","article-title":"X-linked adrenoleukodystrophy and primary adrenal insufficiency","volume":"14","author":"Cappa","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.braindev.2025.104476_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0041-1730937","article-title":"Imaging in X-linked adrenoleukodystrophy","volume":"52","author":"van de Stadt","year":"2021","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2025.104476_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052635","article-title":"X-linked adrenoleukodystrophy: molecular and functional analysis of the ABCD1 gene in Argentinean patients","volume":"7","author":"Amorosi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.braindev.2025.104476_bb0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jdn.10003","article-title":"X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies","volume":"80","author":"Turk","year":"2020","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.braindev.2025.104476_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2018-01307","article-title":"The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration","volume":"104","author":"Huffnagel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10354-016-0534-2","article-title":"Therapeutic strategies in adrenoleukodystrophy","volume":"167","author":"Turk","year":"2017","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.braindev.2025.104476_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","article-title":"Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy","volume":"59","author":"Powers","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.braindev.2025.104476_bb0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-024-03105-0","article-title":"The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology","volume":"19","author":"Yska","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2025.104476_bb0065","first-page":"109","article-title":"The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis","volume":"8","author":"Wiesinger","year":"2015","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.braindev.2025.104476_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-9-6","article-title":"Neurological impairment among heterozygote women for X-linked adrenoleukodystrophy: a case control study on clinical, neurophysiological and biochemical characteristics","volume":"9","author":"Habekost","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2025.104476_bb0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jimd.12356","article-title":"MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines","volume":"44","author":"Mallack","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2025.104476_bb0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ecl.2016.01.003","article-title":"Endocrine dysfunction in X-linked adrenoleukodystrophy","volume":"45","author":"Burtman","year":"2016","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.braindev.2025.104476_bb0085","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3390\/antiox11112125","article-title":"Antioxidant response in human X-linked adrenoleukodystrophy fibroblasts","volume":"11","author":"Petrillo","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.braindev.2025.104476_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","article-title":"Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines","volume":"117","author":"Braverman","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.26502\/jbb.2642-91280151","article-title":"Pathophysiology of X linked adrenoleukodystrophy: updates on molecular mechanisms","volume":"7","author":"Parasar","year":"2024","journal-title":"J Biotechnol Biomed"},{"key":"10.1016\/j.braindev.2025.104476_bb0100","article-title":"Adult-onset cerebral adrenoleukodystrophy without adrenal gland involvement","volume":"12","author":"Mannari","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.braindev.2025.104476_bb0105","article-title":"The role of oxidative stress and inflammation in X-linked adrenoleukodystrophy","volume":"9","author":"Yu","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.braindev.2025.104476_bb0110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/hmg\/ddr536","article-title":"Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy","volume":"21","author":"Schl\u00fcter","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104476_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5479781","article-title":"Identification of two novel mutations of ABCD1 gene in pedigrees with X-linked adrenoleukodystrophy and review of the literature","volume":"2022","author":"Dong","year":"2022","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.braindev.2025.104476_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-019-1008-6","article-title":"Disease progression in women with X-linked adrenoleukodystrophy is slow","volume":"14","author":"Huffnagel","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2025.104476_bb0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/08830738221081141","article-title":"Time to transplant in X-linked adrenoleukodystrophy","volume":"37","author":"Bonkowsky","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.braindev.2025.104476_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12967-023-04493-w","article-title":"Mitochondrial dysfunction in neurodegenerative disorders: potential therapeutic application of mitochondrial transfer to central nervous system-residing cells","volume":"21","author":"Bustamante-Barrientos","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.braindev.2025.104476_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York state: diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"Pt B","key":"10.1016\/j.braindev.2025.104476_bb0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijdevneu.2015.10.001","article-title":"Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients","volume":"47","author":"Deon","year":"2015","journal-title":"Int J Dev Neurosci"},{"issue":"50","key":"10.1016\/j.braindev.2025.104476_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13052-024-01669-y","article-title":"Easily misdiagnosed X-linked adrenoleukodystrophy","volume":"2","author":"Wang","year":"2024","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.braindev.2025.104476_bb0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.braindev.2025.104476_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MED.0000000000000782","article-title":"An update on the diagnosis and treatment of adrenoleukodystrophy","volume":"30","author":"Gujral","year":"2023","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.braindev.2025.104476_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10048-010-0253-6","article-title":"Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes","volume":"12","author":"Matsukawa","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.braindev.2025.104476_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s42003-021-02970-w","article-title":"Structures of the human peroxisomal fatty acid transporter ABCD1 in a lipid environment","volume":"5","author":"Le","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.braindev.2025.104476_bb0175","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","article-title":"Impaired very long-chain acyl-CoA \u03b2-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction","volume":"288","author":"Wiesinger","year":"2013","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.braindev.2025.104476_bb0180","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","article-title":"Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy","volume":"15","author":"Fourcade","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104476_bb0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1471-4159.1976.tb01593.x","article-title":"Brain gangliosides in adrenoleukodystrophy","volume":"27","author":"Garashi","year":"1976","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.braindev.2025.104476_bb0190","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddi140","article-title":"Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy","volume":"14","author":"Asheuer","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104476_bb0195","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1750-3639.2010.00391.x","article-title":"Biochemical aspects of X-linked adrenoleukodystrophy","volume":"20","author":"Kemp","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.braindev.2025.104476_bb0200","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1750-3639.2010.00392.x","article-title":"Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis","volume":"20","author":"Singh","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.braindev.2025.104476_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238796","article-title":"Serum very long-chain fatty acids levels as predictive biomarkers of disease severity and survival in peroxisomal disorders","volume":"15","author":"Stradomska","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.braindev.2025.104476_bb0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method","volume":"97","author":"Hubbard","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.braindev.2025.104476_bb0215","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fcell.2020.00499","article-title":"Adrenoleukodystrophy newborn screening in the Netherlands (SCAN study): the X-factor","volume":"17","author":"Barendsen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.braindev.2025.104476_bb0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2017.10.012","article-title":"Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy","volume":"122","author":"Huffnagel","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0225","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fcell.2020.00690","article-title":"Comparison of the diagnostic performance of C26:0-lysophosphatidylcholine and very long-chain fatty acids analysis for peroxisomal disorders","volume":"8","author":"Jaspers","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.braindev.2025.104476_bb0230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamapediatrics.2024.6774","article-title":"Prognostication and biomarker potential of C26:0 lysophosphatidylcholine in adrenoleukodystrophy","volume":"179","author":"Billington","year":"2025","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.braindev.2025.104476_bb0235","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0240","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.braindev.2025.104476_bb0245","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2025.104476_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsbmb.2016.03.037","article-title":"7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: potential roles of 7-ketocholesterol in the pathophysiology of X-ALD","volume":"169","author":"Nury","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.braindev.2025.104476_bb0255","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamaneurol.2016.5715","article-title":"Antioxidant capacity and superoxide dismutase activity in adrenoleukodystrophy","volume":"74","author":"Turk","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032218","article-title":"Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity","volume":"7","author":"Lund","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.braindev.2025.104476_bb0265","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF02011091","article-title":"Adrenoleukodystrophy: CT and MRI findings","volume":"25","author":"Patel","year":"1995","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.braindev.2025.104476_bb0270","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.bbmt.2020.06.019","article-title":"Volume of gadolinium enhancement and successful repair of the blood-brain barrier in cerebral adrenoleukodystrophy","volume":"26","author":"Lund","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.braindev.2025.104476_bb0275","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/eji.201848043","article-title":"Cerebral adrenoleukodystrophy is associated with loss of tolerance to profilin","volume":"49","author":"Orchard","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.braindev.2025.104476_bb0280","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fcell.2020.00520","article-title":"Multi-omic approach to identify phenotypic modifiers underlying cerebral demyelination in X-linked adrenoleukodystrophy","volume":"8","author":"Richmond","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.braindev.2025.104476_bb0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1742-2094-8-144","article-title":"Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy","volume":"8","author":"Orchard","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.braindev.2025.104476_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.braindev.2025.104476_bb0295","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/awv250","article-title":"Brain endothelial dysfunction in cerebral adrenoleukodystrophy","volume":"138","author":"Musolino","year":"2015","journal-title":"Brain"},{"issue":"135","key":"10.1016\/j.braindev.2025.104476_bb0300","first-page":"47","article-title":"Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X adrenoleukodystrophy","volume":"50","author":"Singh","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.braindev.2025.104476_bb0305","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","article-title":"X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects","volume":"1822","author":"Kemp","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2025.104476_bb0310","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/biom13091333","article-title":"ABCD1 transporter deficiency results in altered cholesterol homeostasis","volume":"13","author":"Buda","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.braindev.2025.104476_bb0315","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3748\/wjg.v20.i7.1746","article-title":"Modulation of hepatic steatosis by dietary fatty acids","volume":"20","author":"Ferramosca","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.braindev.2025.104476_bb0320","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/antiox10050740","article-title":"The controversial role of 24-S-hydroxycholesterol in Alzheimer\u2019s disease","volume":"10","author":"Gamba","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.braindev.2025.104476_bb0325","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0330","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.braindev.2025.104476_bb0335","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1194\/jlr.R067595","article-title":"The role of ER stress in lipid metabolism and lipotoxicity","volume":"57","author":"Han","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.braindev.2025.104476_bb0340","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1093\/brain\/aws292","article-title":"Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy","volume":"135","author":"L\u00f3pez-Erauskin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2025.104476_bb0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","article-title":"Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy","volume":"1688","author":"Vargas","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2025.104476_bb0350","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jnc.12992","article-title":"ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy","volume":"133","author":"Baarine","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.braindev.2025.104476_bb0355","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","article-title":"Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy","volume":"22","author":"L\u00f3pez-Erauskin","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2025.104476_bb0360","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbadis.2015.01.005","article-title":"Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions","volume":"1852","author":"Kruska","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2025.104476_bb0365","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2016.68","article-title":"Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation","volume":"19","author":"Kemper","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.braindev.2025.104476_bb0370","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20356","article-title":"Evaluation of X-linked adrenoleukodystrophy newborn screening in North Carolina","volume":"3","author":"Lee","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.braindev.2025.104476_bb0375","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.cca.2010.08.019","article-title":"A rapid and sensitive protocol for prenatal molecular diagnosis of X-linked adrenoleukodystrophy","volume":"411","author":"Lan","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.braindev.2025.104476_bb0380","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<364::AID-PD525>3.0.CO;2-W","article-title":"Prenatal diagnosis of X-linked adrenoleukodystrophy combining biochemical, immunocytochemical and DNA analyses","volume":"19","author":"Maier","year":"1999","journal-title":"Prenat Diagn"},{"issue":"100","key":"10.1016\/j.braindev.2025.104476_bb0385","first-page":"10","article-title":"Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls","volume":"45","author":"Moser","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0390","first-page":"334","article-title":"Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids","volume":"51","author":"Moser","year":"1998","journal-title":"Neurology"},{"issue":"724","key":"10.1016\/j.braindev.2025.104476_bb0395","first-page":"726","article-title":"Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion","volume":"122","author":"Theda","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2025.104476_bb0400","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11745-013-3761-y","article-title":"The impact of a ketogenic diet and liver dysfunction on serum very long-chain fatty acids levels","volume":"48","author":"Stradomska","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.braindev.2025.104476_bb0405","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1096-7192(03)00098-2","article-title":"Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry","volume":"79","author":"Valianpour","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0410","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1515\/jpem-2020-0652","article-title":"False-positive very long-chain fatty acids in a case of autoimmune adrenal insufficiency","volume":"34","author":"Zhu","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mgme.1998.2779","article-title":"Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy","volume":"66","author":"Boehm","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0420","article-title":"High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan","volume":"32","author":"Chen","year":"2022","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.braindev.2025.104476_bb0425","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/brain\/awy299","article-title":"Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness","volume":"142","author":"Huffnagel","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2025.104476_bb0430","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.braindev.2025.104476_bb0435","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","article-title":"Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy","volume":"61","author":"Loes","year":"2003","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.braindev.2025.104476_bb0440","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.braindev.2025.104476_bb0445","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2025.104476_bb0450","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","article-title":"Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy","volume":"356","author":"Shapiro","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2025.104476_bb0455","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.410210305","article-title":"A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients","volume":"21","author":"Moser","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2025.104476_bb0460","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/BF00968719","article-title":"Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo\u2019s oil)","volume":"19","author":"Rasmussen","year":"1994","journal-title":"Neurochem Res"},{"key":"10.1016\/j.braindev.2025.104476_bb0465","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/mgme.2000.2977","article-title":"Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients","volume":"69","author":"Pai","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2025.104476_bb0470","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/en.2016-1842","article-title":"A thyroid hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy","volume":"158","author":"Hartley","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.braindev.2025.104476_bb0475","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awt143","article-title":"Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy","volume":"136","author":"Morat\u00f3","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2025.104476_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112214","article-title":"Management of adrenoleukodystrophy: from pre-clinical studies to the development of new therapies","volume":"143","author":"Ma","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.braindev.2025.104476_bb0485","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1210\/en.2017-00206","article-title":"Beam me in: thyroid hormone analog targets alternative transporter in mouse model of X-linked adrenoleukodystrophy","volume":"158","author":"Milanesi","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.braindev.2025.104476_bb0490","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMoa2400442","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"391","author":"Eichler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2025.104476_bb0495","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mt.2015.6","article-title":"Adenoassociated virus serotype 9-mediated gene therapy for X-linked adrenoleukodystrophy","volume":"23","author":"Gong","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.braindev.2025.104476_bb0500","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12944-024-02361-0","article-title":"From gene to therapy: a review of deciphering the role of ABCD1 in combating X-linked adrenoleukodystrophy","volume":"23","author":"Zuo","year":"2024","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.braindev.2025.104476_bb0505","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/genes16050590","article-title":"Revisiting the pathogenesis of X-linked adrenoleukodystrophy","volume":"16","author":"Bougn\u00e8res","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.braindev.2025.104476_bb0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00041433-200306000-00005","article-title":"Recent insights into stearoyl-CoA desaturase-1","volume":"14","author":"Ntambi","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.braindev.2025.104476_bb0515","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s43856-024-00605-9","article-title":"Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy","volume":"4","author":"Jaspers","year":"2024","journal-title":"Commun Med (Lond)"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:57:33Z","timestamp":1773219453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760425001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0387760425001585"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104476","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenoleukodystrophy: Current understanding of disease mechanisms, diagnosis, and therapeutic advances\u2013a recent review","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104476"}}